Cancer Drugs

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion

The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link

1 year ago

Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease

Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle…

2 years ago

Obesity Drugs Won't Starve These Other Potential Blockbusters

Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were…

2 years ago

Moderna, Merck Show Progress Toward Cancer Vaccines

An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link

2 years ago